uniQure N.V. financial data

Symbol
QURE on Nasdaq
Industry
Pharmaceutical Preparations
Location
Paasheuvelweg 25 A, Amsterdam, Netherlands
Fiscal year end
December 31
Former names
uniQure B.V. (to 2/6/2014)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 800 % -12.9%
Quick Ratio 16.6 % +97.4%
Debt-to-equity 823 % +403%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.1M shares +11.4%
Common Stock, Shares, Outstanding 49M shares +2.41%
Entity Public Float 218M USD -60.1%
Common Stock, Value, Issued 2.95M USD +2.15%
Weighted Average Number of Shares Outstanding, Basic 48.6M shares +2.05%
Weighted Average Number of Shares Outstanding, Diluted 48.6M shares +2.05%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 144M USD -33.1%
Costs and Expenses 215M USD -29.1%
Operating Income (Loss) -184M USD +34.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -237M USD +22.6%
Income Tax Expense (Benefit) 2.43M USD +26.4%
Earnings Per Share, Basic -4.92 USD/shares +24%
Earnings Per Share, Diluted -4.92 USD/shares +24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 159M USD -34.2%
Inventory, Net 7.67M USD +2.61%
Assets, Current 390M USD -40.1%
Deferred Income Tax Assets, Net 9.86M USD -19.7%
Property, Plant and Equipment, Net 20.4M USD -56.1%
Operating Lease, Right-of-Use Asset 13.6M USD -52.6%
Intangible Assets, Net (Excluding Goodwill) 71M USD +17.5%
Goodwill 22.4M USD -15%
Other Assets, Noncurrent 1.4M USD -56.1%
Assets 557M USD -33.1%
Accounts Payable, Current 7.23M USD +9.73%
Employee-related Liabilities, Current 12.6M USD -22.6%
Accrued Liabilities, Current 29.2M USD -4.29%
Liabilities, Current 40.1M USD -45.6%
Deferred Income Tax Liabilities, Net 7.04M USD -6.63%
Operating Lease, Liability, Noncurrent 11.1M USD -60.7%
Other Liabilities, Noncurrent 7.94M USD +115%
Liabilities 563M USD -9.73%
Accumulated Other Comprehensive Income (Loss), Net of Tax -52.8M USD +1.41%
Retained Earnings (Accumulated Deficit) -1.13B USD -26.9%
Stockholders' Equity Attributable to Parent -6.75M USD -103%
Liabilities and Equity 557M USD -33.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -60.6M USD +22.6%
Net Cash Provided by (Used in) Financing Activities 131K USD -73%
Net Cash Provided by (Used in) Investing Activities 64M USD +2041%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 49M shares +2.41%
Common Stock, Par or Stated Value Per Share 0.05 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.69M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 160M USD -34.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.76M USD +55.7%
Deferred Tax Assets, Valuation Allowance 192M USD +32.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.26 pure 0%
Deferred Tax Assets, Gross 213M USD +22.3%
Operating Lease, Liability 14.7M USD -59.8%
Payments to Acquire Property, Plant, and Equipment 2.34M USD +0.09%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -239M USD +21.4%
Lessee, Operating Lease, Liability, to be Paid 20M USD -60%
Property, Plant and Equipment, Gross 52.1M USD -49.1%
Operating Lease, Liability, Current 3.6M USD -56.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.59M USD -56.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.6M USD -57%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Deferred Income Tax Expense (Benefit) -1.21M USD -95.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.24M USD -60.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.41M USD -59.1%
Deferred Tax Assets, Operating Loss Carryforwards 178M USD +22.4%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.38M USD -59.2%
Additional Paid in Capital 1.17B USD +2.12%
Deferred Tax Assets, Net of Valuation Allowance 21.2M USD -26.9%
Interest Expense 54.1M USD +324%